BioCryst Pharmaceuticals
BCRXBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at BioCryst Pharmaceuticals
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 5/18/2026 | Sell | $9.0 | $100,285 |
| 5/13/2026 | Sell | $9.5 | $596,250 |
| 3/20/2026 | Sell | $10.1 | $504,823 |
| 3/16/2026 | Sell | $9.2 | $1,372,500 |
| 12/22/2025 | Sell | $7.6 | $166,563 |
| 12/15/2025 | Sell | $7.6 | $162,257 |
| 12/3/2025 | Sell | $7.6 | $151,241 |
| 12/2/2025 | Sell | $7.2 | $367,216 |
| 12/1/2025 | Sell | $7.1 | $646,511 |
| 11/13/2025 | Sell | $7.1 | $68,544 |
| 8/13/2025 | Sell | $8.5 | $595,868 |
| 12/13/2024 | Sell | $7.5 | $52,780 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)